Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Hosts.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31253580.
- Also identified by DOI 10.1016/j.jaip.2019.05.051 and PMC identifier 6733665.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antibiotic allergies are reported in up to 1 in 4 immunocompromised hosts with significant impacts on antibiotic utilization and patient outcomes. Health services programs focused on de-labeling beta-lactam and sulfonamide allergy labels should be a standard of care in immunocompromised hosts.
Medical subject headings
- Anti-Bacterial Agents
- Drug Hypersensitivity
- Immunocompromised Host
- Sulfonamides
- beta-Lactams